Analyst Viewpoint
Rise in preference for home healthcare and ongoing technological advancements in wearable injector design and manufacturing are driving the wearable injectors market development. The presence of an ever-expanding healthcare sector is playing an integral role in driving sales of wearable injectors across the globe.
Wearable injectors have emerged as a self-scalable and self-administered technology that can help patients in ensuring a regular intake of medical dosage. The need for administering the right amount of medical fluid has brought wearable injectors under the spotlight of attention.
Vendors in the wearable injectors market landscape are seeking the approval and launch of new products to expand their product portfolio.
Wearable injectors are drug-delivery devices that automatically deliver set doses to the patient at optimal times. These injectors adhere to the body and are often used for chronic conditions that require regular injections.
Wearable injection systems are considered the natural evolution of chronic disease management they offer a more convenient and user-friendly method of administering medications. These systems eliminate the need for a patient to travel to a healthcare provider for drug administration, thus relieving the burden on the healthcare sector.
Subcutaneous injection is gaining traction as a prominent method of drug administration. Rise in preference for fixed-dose regimens for antibody-based drugs is projected to positively impact the wearable injectors industry growth in the near future.
Patch injectors are widely utilized in administering highly potent subcutaneous oncology drugs. The use of wearable drug infusion systems is extending to new indication areas in neurology.
Patients are increasingly shifting from in-clinic to at-home treatment, creating a need for more “patient-friendly” solutions than traditional vial-and-syringe or prefilled syringe presentations. Most therapies that were previously delivered via the intravenous (IV) route are being reformulated for subcutaneous (SC) infusion at home. On-body Delivery Systems (OBDSs) are enabling new drugs to be delivered at home.
Most wearable injectors offer a connectivity solution to connect with apps and mobile devices. These features are boosting the preference for home care settings, thereby propelling the wearable injectors market size.
Injection frequency has been reduced (biweekly to monthly to quarterly), thereby boosting the preference for wearable on-body devices over handheld autoinjectors. Wearable on-body devices help decrease the injection duration.
Patients are seeking smart injection wearables that offer high wearability and usability. These wearables offer ease of use, increased mobility during infusion, reduced setup time, and reduced pain at the injection site.
Technological advancements, both in terms of the delivery system and the development of new drugs are driving the growth of the wearable injectors industry. Many drugs require special delivery devices to be administered efficiently to patients. Expansion in the biopharmaceutical sector is driving the development of innovative drugs, which in turn encourages the demand for wearable injectors.
Major wearable injector manufacturers are offering a wide portfolio of prefillable syringes for vaccination needs. These prefillable syringes meet the complex and evolving needs of vaccine manufacturing.
Manufacturers are also offering advanced products that address chronic disease outcomes in areas such as diabetes, obesity, oncology, and autoimmune disorders. Self-injection systems are gaining traction among end-users. These systems support the subcutaneous delivery of drugs across a broad range of volume and viscosity needs.
North America held largest wearable injectors market share in 2022. Advancements in medical research, wearable devices, and fluid administration are fueling the market expansion in the region. Growth in focus on developing novel technologies for the subcutaneous administration of fluids is also propelling the market value in North America.
Rise in home healthcare expenditure and increase in focus on patient-centric drug delivery are major wearable injectors market trends in the region. Spending for services provided by freestanding home healthcare agencies in the U.S. increased 6.0% in 2022 to US$ 132.9 billion, accelerating from growth of 0.3% in 2021, according to the Centers for Medicare & Medicaid Services.
According to the latest wearable injectors market forecast, the industry in Asia Pacific is projected to grow at a steady pace from 2023 to 2031. Growth in prevalence of chronic diseases and rise in healthcare awareness are boosting the market trajectory in the region.
Wearable injector companies are developing patient-centric devices for use in at-home settings. They are offering devices that help mitigate the risk of potential misuse for patients who struggle with too many use steps.
BD, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., Insulet Corporation, Ypsomed AG, West Pharmaceutical Services, Inc., CeQur Corporation, Debiotech S.A., Sensile Medical AG (Gerresheimer AG), and United Therapeutics Corporation are major vendors operating in this market.
The wearable injectors market report highlights these companies in terms of parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 6.8 Bn |
| Market Forecast Value in 2031 | US$ 12.4 Bn |
| Growth Rate (CAGR) | 7.1% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 6.8 Bn in 2022
It is projected to grow at a CAGR of 7.1% from 2023 to 2031
Rise in preference for home healthcare and ongoing technological advancements in wearable injector design and manufacturing
North America was the most lucrative region in 2022
BD, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., Insulet Corporation, Ypsomed AG, West Pharmaceutical Services, Inc., CeQur Corporation, Debiotech S.A., Sensile Medical AG (Gerresheimer AG), and United Therapeutics Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Wearable Injectors Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Wearable Injectors Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Wearable Injectors Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. On-body Wearable Injectors
6.3.2. Off-body Wearable Injectors
6.4. Market Attractiveness Analysis, by Type
7. Global Wearable Injectors Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Oncology
7.3.2. Diabetes
7.3.3. Autoimmune Disorders
7.3.4. Cardiovascular Diseases
7.3.5. Infectious Diseases
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Wearable Injectors Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Home Care Settings
8.3.4. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Wearable Injectors Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Wearable Injectors Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type, 2017–2031
10.3.1. On-body Wearable Injectors
10.3.2. Off-body Wearable Injectors
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Oncology
10.4.2. Diabetes
10.4.3. Autoimmune Disorders
10.4.4. Cardiovascular Diseases
10.4.5. Infectious Diseases
10.4.6. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Home Care Settings
10.5.4. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Wearable Injectors Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type, 2017–2031
11.3.1. On-body Wearable Injectors
11.3.2. Off-body Wearable Injectors
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Oncology
11.4.2. Diabetes
11.4.3. Autoimmune Disorders
11.4.4. Cardiovascular Diseases
11.4.5. Infectious Diseases
11.4.6. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Home Care Settings
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Wearable Injectors Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type, 2017–2031
12.3.1. On-body Wearable Injectors
12.3.2. Off-body Wearable Injectors
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Oncology
12.4.2. Diabetes
12.4.3. Autoimmune Disorders
12.4.4. Cardiovascular Diseases
12.4.5. Infectious Diseases
12.4.6. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Home Care Settings
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Wearable Injectors Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type, 2017–2031
13.3.1. On-body Wearable Injectors
13.3.2. Off-body Wearable Injectors
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Oncology
13.4.2. Diabetes
13.4.3. Autoimmune Disorders
13.4.4. Cardiovascular Diseases
13.4.5. Infectious Diseases
13.4.6. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Home Care Settings
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Wearable Injectors Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type, 2017–2031
14.3.1. On-body Wearable Injectors
14.3.2. Off-body Wearable Injectors
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Oncology
14.4.2. Diabetes
14.4.3. Autoimmune Disorders
14.4.4. Cardiovascular Diseases
14.4.5. Infectious Diseases
14.4.6. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Home Care Settings
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. BD
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. F. Hoffmann-La Roche Ltd.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Tandem Diabetes Care, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Insulet Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Ypsomed AG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. West Pharmaceutical Services, Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. CeQur Corporation
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Debiotech S.A.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Sensile Medical AG (Gerresheimer AG)
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. United Therapeutics Corporation
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 07: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 11: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 15: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 19: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2017–2031
Table 23: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Wearable Injectors Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Wearable Injectors Market Revenue (US$ Mn), by Type, 2022
Figure 03: Global Wearable Injectors Market Value Share, by Type, 2022
Figure 04: Global Wearable Injectors Market Revenue (US$ Mn), by Application, 2022
Figure 05: Global Wearable Injectors Market Value Share, by Application, 2022
Figure 06: Global Wearable Injectors Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Wearable Injectors Market Value Share, by End-user, 2022
Figure 08: Global Wearable Injectors Market Value Share, by Region, 2022
Figure 09: Global Wearable Injectors Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Wearable Injectors Market Value Share Analysis, by Type, 2022–2031
Figure 11: Global Wearable Injectors Market Attractiveness Analysis, by Type, 2023-2031
Figure 12: Global Wearable Injectors Market Value Share Analysis, by Application, 2022–2031
Figure 13: Global Wearable Injectors Market Attractiveness Analysis, by Application, 2023-2031
Figure 14: Global Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031
Figure 15: Global Wearable Injectors Market Attractiveness Analysis, by End-user, 2023-2031
Figure 16: Global Wearable Injectors Market Value Share Analysis, by Region, 2022–2031
Figure 17: Global Wearable Injectors Market Attractiveness Analysis, by Region, 2023-2031
Figure 18: North America Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Wearable Injectors Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Wearable Injectors Market Value Share Analysis, by Country, 2022–2031
Figure 21: North America Wearable Injectors Market Value Share Analysis, by Type, 2022–2031
Figure 22: North America Wearable Injectors Market Value Share Analysis, by Application, 2022–2031
Figure 23: North America Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031
Figure 24: North America Wearable Injectors Market Attractiveness Analysis, by Type, 2023–2031
Figure 25: North America Wearable Injectors Market Attractiveness Analysis, by Application, 2023–2031
Figure 26: North America Wearable Injectors Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 30: Europe Wearable Injectors Market Value Share Analysis, by Type, 2022–2031
Figure 31: Europe Wearable Injectors Market Value Share Analysis, by Application, 2022–2031
Figure 32: Europe Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031
Figure 33: Europe Wearable Injectors Market Attractiveness Analysis, by Type, 2023–2031
Figure 34: Europe Wearable Injectors Market Attractiveness Analysis, by Application, 2023–2031
Figure 35: Europe Wearable Injectors Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 39: Asia Pacific Wearable Injectors Market Value Share Analysis, by Type, 2022–2031
Figure 40: Asia Pacific Wearable Injectors Market Value Share Analysis, by Application, 2022–2031
Figure 41: Asia Pacific Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031
Figure 42: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by Type, 2023–2031
Figure 43: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by Application, 2023–2031
Figure 44: Asia Pacific Wearable Injectors Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Wearable Injectors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 48: Latin America Wearable Injectors Market Value Share Analysis, by Type, 2022–2031
Figure 49: Latin America Wearable Injectors Market Value Share Analysis, by Application, 2022–2031
Figure 50: Latin America Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031
Figure 51: Latin America Wearable Injectors Market Attractiveness Analysis, by Type, 2023–2031
Figure 52: Latin America Wearable Injectors Market Attractiveness Analysis, by Application, 2023–2031
Figure 53: Latin America Wearable Injectors Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Wearable Injectors Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 57: Middle East & Africa Wearable Injectors Market Value Share Analysis, by Type, 2022–2031
Figure 58: Middle East & Africa Wearable Injectors Market Value Share Analysis, by Application, 2022–2031
Figure 59: Middle East & Africa Wearable Injectors Market Value Share Analysis, by End-user, 2022–2031
Figure 60: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by Type, 2023–2031
Figure 61: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by Application, 2023–2031
Figure 62: Middle East & Africa Wearable Injectors Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Wearable Injectors Market
*86 figures and 60 tables includes